Skip to main content
Premium Trial:

Request an Annual Quote

Protein Biomarker Shop Peakadilly Closes $10.9M in VC Round

NEW YORK (GenomeWeb News) – Protein biomarker company Peakadilly today said it has raised €8.5 million ($10.9 million) in the second and final round of its series A financing.
Peakadilly said it will use the cash to increase the capacity of its protein biomarker-discovery operation, which is based on its MASStermind technology.
It will also enable it to “accelerate development of its own diagnostic and pharmacodiagnostic products,” the firm said.
The investment brings to €14.5 million the total amount of venture capital Peakadilly has raised. The Ghent, Belgium-based company raised €6 million in March in its first series A round.
Investors in the second round were GIMV, Life Science Partners, KBC Private Equity, and Baekeland Fonds II. 

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.